Cervical cancer is one of the widespread cancers in girls accounting for 7.9% of all cancers. In India it’s the second commonest cancer in girls. The immortality of the cancer cell and the comparatively lengthy timeframe from acquisition of an infection to growth of cervical cancer was established.
As main developments like LBC, HPV testing have been launched within the current years, screening has taken a brand new avatar, the Molecular pap!! The goals of this research have been: To evaluate gynecologic cytology and irregular outcomes with respect to standard and LBC. To research the function of HPV cotesting and ancillary checks carried out, that’s, HPV CISH, and p16ink4a by IHC.
About 71 924 Conventional and LBC samples have been included from August 2009 to December 2017. Cases for HPV testing alongside the traditional smears have been 1539. HPV could be examined from the identical LBC vial because the pattern stays steady at room temperature for six weeks. HPV DNA PCR was carried out in our laboratory for High and Low danger genotypes.
Cytology findings have been additionally correlated with histology. Detection charge of SILs in LBC samples have been greater (2.20%). The commonest abnormality was LSIL in LBC and ASCUS in typical smears. LBC with HPV cotesting improves sensitivity and specificity and reduces ambiguous outcomes; permits higher compliance, as a adverse outcome of each checks permits sufferers to get screening each 5 years, thereby rising screening intervals, essential in a useful resource restricted state of affairs.
Touch imprint (TI) cytology of needle core biopsies (NCB) in pathology laboratories: A observe survey of contributors within the College of American Pathologists (CAP) Non Gynecologic Cytopathology (NGC) Education Program.
Intra-procedural evaluation of contact imprint (TI) cytology from needle core biopsies (NCB) is used to make sure pattern adequacy and to offer rapid prognosis in numerous settings. We aimed to survey laboratories for present practices on the use of cytology with NCB. A voluntary supplemental questionnaire together with questions on demographics, personnel concerned, websites, accessioning, and reporting was despatched with the College of American Pathologists (CAP) 2015 Non gynecologic Cytopathology Education Program to survey practices of cytologic evaluation of NCB.
Among 844 respondents, 403 (48%) carried out cytologic evaluation of NCB. Common physique websites included lung (94%; 368/392), liver (87%; 340/ 392), and lymph nodes/spleen (77%; 303/392). Most of the time, a pathologist was current on-site 75% (295/393) for adequacy evaluation which was often verbally reported to the supplier performing the process.
Specimens have been ready by cytotechnologists (50%; 193 of 388) or pathologists (45%; 176 of 388) by touching the core to the slide (50%; 196 of 390) and rolling the core on the slide (45%; 177/390). Among the respondents, 19% stated that cytotechnologists independently carried out rapid evaluation of TI of NCB. Most laboratories (69%; 264/384) evaluated air-dried slides with a modified Giemsa stain and rendered one TI/NCB mixed report (87%, 334/385).

p16/Ki-67 dual-stained cytology for detecting cervical (pre)cancer in a HPV-positive gynecologic outpatient inhabitants.
Women who check optimistic for a high-risk sort of the human papillomavirus (HPV) require triage testing to determine these girls with cervical intraepithelial neoplasia grade Three or cancer (≥CIN3). Although Pap cytology is taken into account a gorgeous triage check, its applicability is hampered by its subjective nature. This research prospectively in contrast the scientific efficiency of p16/Ki-67 dual-stained cytology to that of Pap cytology, with or with out HPV16/18 genotyping, in high-risk HPV-positive girls visiting gynecologic outpatient clinics (n=446 and age 18-66 years).
From all girls, cervical scrapes (for Pap cytology, HPV16/18 genotyping, and p16/Ki-67 dual-stained cytology) and colposcopy-directed biopsies have been obtained. This is the primary survey carried out particularly to find out the observe of adequacy evaluation of TI of NCB. Cytotechnologists are usually not performing adequacy evaluation of TI with out pathologist oversight. A single report is often issued which incorporates the adequacy evaluation as a component of the ultimate report.
The sensitivity of p16/Ki-67 dual-stained cytology for ≥CIN3 (93.8%) did neither differ considerably from that of Pap cytology (87.7%; ratio 1.07 and 95% confidence interval (CI): 0.97-1.18) nor from that of Pap cytology mixed with HPV16/18 genotyping (95.1%; ratio 0.99 and 95% CI: 0.91-1.07). However, the specificity of p16/Ki-67 dual-stained cytology for ≥CIN3 (51.2%) was considerably greater than that of Pap cytology (44.9%; ratio 1.14 and 95% CI: 1.01-1.29) and Pap cytology mixed with HPV16/18 genotyping (25.8%; ratio 1.99 and 95% CI: 1.68-2.35).
After exclusion of girls who had been referred as a result of of irregular Pap cytology, the specificity of p16/Ki-67 dual-stained cytology for ≥CIN3 (56.7%) remained the identical, whereas that of Pap cytology (60.3%) elevated considerably, leading to the same specificity of each assays (ratio 0.94 and 95% CI: 0.83-1.07) on this sub-cohort. In abstract, p16/Ki-67 dual-stained cytology has a superb scientific efficiency and is an fascinating goal microscopy-based triage device for high-risk HPV-positive girls.
Fully Automatic Liquid-Based Cytology & Immunocytochemistry Stainer |
|
CNT430 |
Celnovte Biotechnology |
32 Slides |
Ask for price |
Gill’s Hematoxylin #2, double strength for Histology & Cytology |
|
24243-1000 |
Polysciences Europe GmbH |
1000ml |
EUR 83.16 |
|
Description: 7732-18-5 |
Gill’s Hematoxylin #2, double strength for Histology & Cytology |
|
24243-500 |
Polysciences Europe GmbH |
500ml |
EUR 60.48 |
|
Description: 7732-18-5 |
DNA-Sorb-D
DNA extraction kit from liquid-based cytology samples (Cytoscreen, |
|
K-1-8-100 |
Sacace Biotechnologies |
100 |
EUR 245.25 |
Blood Brain Barrier Transportation Media |
|
TMBBB001 |
Alphabioregen |
500ml bottle |
EUR 0.1 |
Viral Transport Medium |
|
MBS136572-1L |
MyBiosource |
1L |
EUR 475 |
Viral Transport Medium |
|
MBS136572-500mL |
MyBiosource |
500mL |
EUR 295 |
Viral Transport Medium |
|
MBS136572-5x1L |
MyBiosource |
5x1L |
EUR 1995 |
Viral Transport Medium |
|
IGVTM1000ML |
Innovative research |
each |
EUR 317 |
|
|
|
Description: Viral Transport Medium |
Viral Transport Medium |
|
IGVTM500ML |
Innovative research |
each |
EUR 168 |
|
|
|
Description: Viral Transport Medium |
Viral Transport Medium |
|
TRI-C85L1 |
TRI Biotech |
1000mL |
EUR 705.6 |
Viral Transport Medium |
|
TRI-C85M1 |
TRI Biotech |
200mL |
EUR 146.16 |
Viral Transport Medium |
|
TRI-C85S1 |
TRI Biotech |
100mL |
EUR 73.08 |
Transport Charcoal Medium |
|
33544-1 |
Sisco Laboratories |
500 Gms |
EUR 39.34 |
|
|
|
Description: Part D |
Amies Transport Medium w/ Charcoal |
|
98349 |
Sisco Laboratories |
100 Gms |
EUR 9.41 |
|
|
|
Description: Part D |
Amies Transport Medium w/ Charcoal |
|
98349-1 |
Sisco Laboratories |
500 Gms |
EUR 29.08 |
|
|
|
Description: Part D |
Viral Transport Medium Liquid Amies |
|
MBS136573-1L |
MyBiosource |
1L |
EUR 270 |
Viral Transport Medium Liquid Amies |
|
MBS136573-500mL |
MyBiosource |
500mL |
EUR 200 |
Viral Transport Medium Liquid Amies |
|
MBS136573-5x1L |
MyBiosource |
5x1L |
EUR 1070 |
Viral Transport Medium Liquid Amies |
|
IGVTMA1000ML |
Innovative research |
each |
EUR 145 |
|
|
|
Description: Viral Transport Medium Liquid Amies |
Viral Transport Medium Liquid Amies |
|
IGVTMA500ML |
Innovative research |
each |
EUR 81 |
|
|
|
Description: Viral Transport Medium Liquid Amies |
Viral Transport Medium Veal Infusion |
|
MBS136574-1L |
MyBiosource |
1L |
EUR 265 |
Viral Transport Medium Veal Infusion |
|
MBS136574-500mL |
MyBiosource |
500mL |
EUR 200 |
Viral Transport Medium Veal Infusion |
|
MBS136574-5x1L |
MyBiosource |
5x1L |
EUR 1055 |
Viral Transport Medium Veal Infusion |
|
IGVTMV1000ML |
Innovative research |
each |
EUR 141 |
|
|
|
Description: Viral Transport Medium Veal Infusion |
Viral Transport Medium Veal Infusion |
|
IGVTMV500ML |
Innovative research |
each |
EUR 81 |
|
|
|
Description: Viral Transport Medium Veal Infusion |
Amies Transport Medium w/o Charcoal |
|
24193 |
Sisco Laboratories |
100 Gms |
EUR 9.41 |
|
|
|
Description: Part D |
Amies Transport Medium w/o Charcoal |
|
24193-1 |
Sisco Laboratories |
500 Gms |
EUR 29.08 |
|
|
|
Description: Part D |
Cyclin And CBS Domain Divalent Metal Cation Transport Mediator 2 (CNNM2) Antibody |
|
abx027854-400l |
Abbexa |
400 µl |
EUR 518.75 |
Cyclin And CBS Domain Divalent Metal Cation Transport Mediator 2 (CNNM2) Antibody |
|
abx027854-400ul |
Abbexa |
400 ul |
EUR 627.6 |
|
|
Cyclin And CBS Domain Divalent Metal Cation Transport Mediator 2 (CNNM2) Antibody |
|
abx027854-80l |
Abbexa |
80 µl |
EUR 281.25 |
|
|
Cyclin And CBS Domain Divalent Metal Cation Transport Mediator 2 (CNNM2) Antibody |
|
abx015115-100g |
Abbexa |
100 µg |
EUR 43.75 |
Cyclin And CBS Domain Divalent Metal Cation Transport Mediator 2 (CNNM2) Antibody |
|
20-abx015115 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 5 ug
- 10 ug
- 100 ug
- 200 ug
- 300 µg
|
|
|
Cyclin And CBS Domain Divalent Metal Cation Transport Mediator 2 (CNNM2) Antibody |
|
abx330898-100ul |
Abbexa |
100 ul |
EUR 510 |
|
|
Cyclin And CBS Domain Divalent Metal Cation Transport Mediator 1 (CNNM1) Antibody |
|
abx375911-96tests |
Abbexa |
96 tests |
EUR 337.5 |
Cyclin And CBS Domain Divalent Metal Cation Transport Mediator 2 (CNNM2) Antibody |
|
abx327220-100g |
Abbexa |
100 µg |
EUR 250 |
Cyclin And CBS Domain Divalent Metal Cation Transport Mediator 2 (CNNM2) Antibody |
|
20-abx327220 |
Abbexa |
-
Ask for price
-
Ask for price
|
|
|
|
Cyclin And CBS Domain Divalent Metal Cation Transport Mediator 2 (CNNM2) Antibody |
|
abx327220-50g |
Abbexa |
50 µg |
EUR 187.5 |
Cyclin And CBS Domain Divalent Metal Cation Transport Mediator 1 (CNNM1) Antibody |
|
20-abx147914 |
Abbexa |
-
Ask for price
-
Ask for price
|
|
|
|
Cyclin And CBS Domain Divalent Metal Cation Transport Mediator 1 (CNNM1) Antibody |
|
abx147914-1096tests |
Abbexa |
10 × 96 tests |
Ask for price |
Cyclin And CBS Domain Divalent Metal Cation Transport Mediator 1 (CNNM1) Antibody |
|
abx147914-596tests |
Abbexa |
5 × 96 tests |
EUR 387.5 |
Cyclin And CBS Domain Divalent Metal Cation Transport Mediator 1 (CNNM1) Antibody |
|
abx147914-96tests |
Abbexa |
96 tests |
EUR 300 |
Cyclin And CBS Domain Divalent Metal Cation Transport Mediator 1 (CNNM1) Antibody |
|
abx311414-100g |
Abbexa |
100 µg |
EUR 362.5 |
Cyclin And CBS Domain Divalent Metal Cation Transport Mediator 1 (CNNM1) Antibody |
|
20-abx311414 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 20 ug
- 50 ug
- 100 ug
- 200 ug
- 1 mg
|
|
|
Cyclin And CBS Domain Divalent Metal Cation Transport Mediator 1 (CNNM1) Antibody |
|
abx311414-20g |
Abbexa |
20 µg |
EUR 162.5 |
Cyclin And CBS Domain Divalent Metal Cation Transport Mediator 1 (CNNM1) Antibody |
|
abx311414-50g |
Abbexa |
50 µg |
EUR 250 |
Cyclin And CBS Domain Divalent Metal Cation Transport Mediator 1 (CNNM1) Antibody (HRP) |
|
abx311415-100g |
Abbexa |
100 µg |
EUR 362.5 |
Cyclin And CBS Domain Divalent Metal Cation Transport Mediator 1 (CNNM1) Antibody (HRP) |
|
20-abx311415 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 20 ug
- 50 ug
- 100 ug
- 200 ug
- 1 mg
|
|
|
Cyclin And CBS Domain Divalent Metal Cation Transport Mediator 1 (CNNM1) Antibody (HRP) |
|
abx311415-20g |
Abbexa |
20 µg |
EUR 162.5 |
Cyclin And CBS Domain Divalent Metal Cation Transport Mediator 1 (CNNM1) Antibody (HRP) |
|
abx311415-50g |
Abbexa |
50 µg |
EUR 250 |
Cyclin And CBS Domain Divalent Metal Cation Transport Mediator 1 (CNNM1) Antibody (FITC) |
|
abx311416-100g |
Abbexa |
100 µg |
EUR 362.5 |
Cyclin And CBS Domain Divalent Metal Cation Transport Mediator 1 (CNNM1) Antibody (FITC) |
|
20-abx311416 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 20 ug
- 50 ug
- 100 ug
- 200 ug
- 1 mg
|
|
|
Cyclin And CBS Domain Divalent Metal Cation Transport Mediator 1 (CNNM1) Antibody (FITC) |
|
abx311416-20g |
Abbexa |
20 µg |
EUR 162.5 |
Cyclin And CBS Domain Divalent Metal Cation Transport Mediator 1 (CNNM1) Antibody (FITC) |
|
abx311416-50g |
Abbexa |
50 µg |
EUR 250 |
Rat Cyclin And CBS Domain Divalent Metal Cation Transport Mediator 2 (CNNM2) ELISA Kit |
|
abx507610-96tests |
Abbexa |
96 tests |
EUR 687.5 |
Cyclin And CBS Domain Divalent Metal Cation Transport Mediator 1 (CNNM1) Antibody (Biotin) |
|
abx311417-100g |
Abbexa |
100 µg |
EUR 362.5 |
Cyclin And CBS Domain Divalent Metal Cation Transport Mediator 1 (CNNM1) Antibody (Biotin) |
|
20-abx311417 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 20 ug
- 50 ug
- 100 ug
- 200 ug
- 1 mg
|
|
|
Cyclin And CBS Domain Divalent Metal Cation Transport Mediator 1 (CNNM1) Antibody (Biotin) |
|
abx311417-20g |
Abbexa |
20 µg |
EUR 162.5 |
Cyclin And CBS Domain Divalent Metal Cation Transport Mediator 1 (CNNM1) Antibody (Biotin) |
|
abx311417-50g |
Abbexa |
50 µg |
EUR 250 |
Cnnm4 (untagged) - Rat cyclin and CBS domain divalent metal cation transport mediator 4 (Cnnm4) |
|
RN217195 |
Origene Technologies GmbH |
10 µg |
Ask for price |
Amies Medium w/o Charcoal (Amies Transport Medium) (Powder) |
|
MBS652695-100g |
MyBiosource |
100g |
EUR 255 |
Amies Medium w/o Charcoal (Amies Transport Medium) (Powder) |
|
MBS652695-1kg |
MyBiosource |
1kg |
EUR 655 |
Amies Medium w/o Charcoal (Amies Transport Medium) (Powder) |
|
MBS652695-25kg |
MyBiosource |
2.5kg |
EUR 1505 |
Amies Medium w/o Charcoal (Amies Transport Medium) (Powder) |
|
MBS652695-500g |
MyBiosource |
500g |
EUR 385 |
Amies Medium w/o Charcoal (Amies Transport Medium) (Powder) |
|
MBS652695-5x25kg |
MyBiosource |
5x2.5kg |
EUR 6500 |
Cary - Blair Transport Medium, Base ( w/o charcoal ) |
|
24715 |
Sisco Laboratories |
100 Gms |
EUR 8.55 |
|
|
|
Description: Part D |
Cary - Blair Transport Medium, Base ( w/o charcoal ) |
|
24715-1 |
Sisco Laboratories |
500 Gms |
EUR 35.07 |
|
|
|
Description: Part D |
Cnnm4 (myc-DDK-tagged) - Rat cyclin and CBS domain divalent metal cation transport mediator 4 (Cnnm4) |
|
RR217195 |
Origene Technologies GmbH |
10 µg |
Ask for price |
Amies Broth with Charcoal (Amies Transport Medium) (Powder) |
|
MBS652724-100g |
MyBiosource |
100g |
EUR 255 |
Amies Broth with Charcoal (Amies Transport Medium) (Powder) |
|
MBS652724-1kg |
MyBiosource |
1kg |
EUR 655 |
Amies Broth with Charcoal (Amies Transport Medium) (Powder) |
|
MBS652724-25kg |
MyBiosource |
2.5kg |
EUR 1505 |
Amies Broth with Charcoal (Amies Transport Medium) (Powder) |
|
MBS652724-500g |
MyBiosource |
500g |
EUR 385 |
Amies Broth with Charcoal (Amies Transport Medium) (Powder) |
|
MBS652724-5x25kg |
MyBiosource |
5x2.5kg |
EUR 6500 |
Transport Canister |
|
M-CBP-PTC1 |
MiTeGen |
1 UNIT |
EUR 500 |
|
Description: Transport Canister |
Sterile Viral Transport and Preservation Medium; Flat Bottom Tube (100 x 1 ml vials) |
|
BSV-VTM-003 |
BioServUK |
100 x 1 ml |
EUR 316 |
|
Description: Sterile Viral Transport and Preservation Medium; Flat Bottom Tube (100 x 1 ml vials) |
Sterile Viral Transport and Preservation Medium; Flat Bottom Tube (500 x 1 ml vials) |
|
BSV-VTM-004 |
BioServUK |
500 x 1 ml |
EUR 1390 |
|
Description: Sterile Viral Transport and Preservation Medium; Flat Bottom Tube (500 x 1 ml vials) |
Sterile Viral Transport and Preservation Medium; Flat Bottom Tube (100 x 3 ml vials) |
|
BSV-VTM-005 |
BioServUK |
100 x 3 ml |
EUR 405 |
|
Description: Sterile Viral Transport and Preservation Medium; Flat Bottom Tube (100 x 3 ml vials) |
Sterile Viral Transport and Preservation Medium; Flat Bottom Tube (500 x 3 ml vials) |
|
BSV-VTM-006 |
BioServUK |
500 x 3 ml |
EUR 1896 |
|
Description: Sterile Viral Transport and Preservation Medium; Flat Bottom Tube (500 x 3 ml vials) |
Recombinant Sinorhizobium medicae C4-dicarboxylate transport protein (dctA), partial |
|
MBS1063783-1mgEColi |
MyBiosource |
1mg(E-Coli) |
EUR 2215 |
Recombinant Sinorhizobium medicae C4-dicarboxylate transport protein (dctA), partial |
|
MBS1063783-1mgYeast |
MyBiosource |
1mg(Yeast) |
EUR 2660 |
ATOX1 (Copper Transport Protein ATOX1, Metal Transport Protein ATX1, HAH1) |
|
MBS643235-01mg |
MyBiosource |
0.1mg |
EUR 630 |
ATOX1 (Copper Transport Protein ATOX1, Metal Transport Protein ATX1, HAH1) |
|
MBS643235-5x01mg |
MyBiosource |
5x0.1mg |
EUR 2680 |
Sterile Viral Transport and Preservation Medium; Conical Bottom Tube (100 x 3 ml vials) |
|
BSV-VTM-001 |
BioServUK |
100 x 3 ml |
EUR 405 |
|
Description: Sterile Viral Transport and Preservation Medium; Conical Bottom Tube (100 x 3 ml vials) |
Sterile Viral Transport and Preservation Medium; Conical Bottom Tube (500 x 3 ml vials) |
|
BSV-VTM-002 |
BioServUK |
500 x 3 ml |
EUR 1896 |
|
Description: Sterile Viral Transport and Preservation Medium; Conical Bottom Tube (500 x 3 ml vials) |
boite de 200 filtres pour cytologie, 24 x 76 mm + 1 trou 7 mm |
|
CY430F2476/1T |
Filtratech |
200 |
EUR 13.1 |
boite de 200 filtres pour cytologie, 26 x 63 mm + 1 trou |
|
CY430F2663/1T |
Filtratech |
200 |
EUR 13.1 |
Sample Transport Reagent |
|
SSFIN-0007 |
Zeptometrix |
20mL |
EUR 32 |
ATOX1 (Copper Transport Protein ATOX1, Metal Transport Protein ATX1, HAH1) (PE) |
|
MBS6156635-01mL |
MyBiosource |
0.1(mL |
EUR 875 |
ATOX1 (Copper Transport Protein ATOX1, Metal Transport Protein ATX1, HAH1) (PE) |
|
MBS6156635-5x01mL |
MyBiosource |
5x0.1mL |
EUR 3800 |
ATOX1 (Copper Transport Protein ATOX1, Metal Transport Protein ATX1, HAH1) (AP) |
|
MBS6130120-01mL |
MyBiosource |
0.1(mL |
EUR 875 |
ATOX1 (Copper Transport Protein ATOX1, Metal Transport Protein ATX1, HAH1) (AP) |
|
MBS6130120-5x01mL |
MyBiosource |
5x0.1mL |
EUR 3800 |
Albumin (Transport Protein) |
|
MBS439947-002mgWithBSAAzideat02mgmL |
MyBiosource |
0.02mg(WithBSA&Azideat0.2mg/mL) |
EUR 230 |
Albumin (Transport Protein) |
|
MBS439947-01mgWithBSAAzideat02mgmL |
MyBiosource |
0.1mg(WithBSA&Azideat0.2mg/mL) |
EUR 405 |
Albumin (Transport Protein) |
|
MBS439947-01mgWithoutBSAAzideat1mgmL |
MyBiosource |
0.1mg(WithoutBSA&Azideat1mg/mL) |
EUR 405 |
Albumin (Transport Protein) |
|
MBS439947-5x01mgWithBSAAzideat02mgmL |
MyBiosource |
5x0.1mg(WithBSA&Azideat0.2mg/mL) |
EUR 1725 |
Albumin (Transport Protein) |
|
MBS439947-5x01mgWithoutBSAAzideat1mgmL |
MyBiosource |
5x0.1mg(WithoutBSA&Azideat1mg/mL) |
EUR 1725 |
Albumin (Transport Protein) |
|
MBS4380885-002mgWithBSAAzideat02mgmL |
MyBiosource |
0.02mg(WithBSA&Azideat0.2mg/mL) |
EUR 230 |
Albumin (Transport Protein) |
|
MBS4380885-01mgWithBSAAzideat02mgmL |
MyBiosource |
0.1mg(WithBSA&Azideat0.2mg/mL) |
EUR 405 |
Albumin (Transport Protein) |
|
MBS4380885-01mgWithoutBSAAzideat1mgmL |
MyBiosource |
0.1mg(WithoutBSA&Azideat1mg/mL) |
EUR 405 |
Albumin (Transport Protein) |
|
MBS4380885-5x01mgWithBSAAzideat02mgmL |
MyBiosource |
5x0.1mg(WithBSA&Azideat0.2mg/mL) |
EUR 1725 |
Albumin (Transport Protein) |
|
MBS4380885-5x01mgWithoutBSAAzideat1mgmL |
MyBiosource |
5x0.1mg(WithoutBSA&Azideat1mg/mL) |
EUR 1725 |
Albumin (Transport Protein) |
|
MBS4380886-002mgWithBSAAzideat02mgmL |
MyBiosource |
0.02mg(WithBSA&Azideat0.2mg/mL) |
EUR 230 |
Albumin (Transport Protein) |
|
MBS4380886-01mgWithBSAAzideat02mgmL |
MyBiosource |
0.1mg(WithBSA&Azideat0.2mg/mL) |
EUR 405 |
Albumin (Transport Protein) |
|
MBS4380886-01mgWithoutBSAAzideat1mgmL |
MyBiosource |
0.1mg(WithoutBSA&Azideat1mg/mL) |
EUR 405 |
Albumin (Transport Protein) |
|
MBS4380886-5x01mgWithBSAAzideat02mgmL |
MyBiosource |
5x0.1mg(WithBSA&Azideat0.2mg/mL) |
EUR 1725 |
Albumin (Transport Protein) |
|
MBS4380886-5x01mgWithoutBSAAzideat1mgmL |
MyBiosource |
5x0.1mg(WithoutBSA&Azideat1mg/mL) |
EUR 1725 |
Albumin (Transport Protein) |
|
MBS4380887-05mL |
MyBiosource |
0.5mL |
EUR 405 |
Albumin (Transport Protein) |
|
MBS4380887-5x05mL |
MyBiosource |
5x0.5mL |
EUR 1725 |
Albumin (Transport Protein) |
|
MBS4380888-002mgWithBSAAzideat02mgmL |
MyBiosource |
0.02mg(WithBSA&Azideat0.2mg/mL) |
EUR 230 |
Albumin (Transport Protein) |
|
MBS4380888-01mgWithBSAAzideat02mgmL |
MyBiosource |
0.1mg(WithBSA&Azideat0.2mg/mL) |
EUR 405 |
Albumin (Transport Protein) |
|
MBS4380888-01mgWithoutBSAAzideat1mgmL |
MyBiosource |
0.1mg(WithoutBSA&Azideat1mg/mL) |
EUR 405 |
Albumin (Transport Protein) |
|
MBS4380888-5x01mgWithBSAAzideat02mgmL |
MyBiosource |
5x0.1mg(WithBSA&Azideat0.2mg/mL) |
EUR 1725 |
Albumin (Transport Protein) |
|
MBS4380888-5x01mgWithoutBSAAzideat1mgmL |
MyBiosource |
5x0.1mg(WithoutBSA&Azideat1mg/mL) |
EUR 1725 |
Albumin (Transport Protein) |
|
MBS4380889-002mgWithBSAAzideat02mgmL |
MyBiosource |
0.02mg(WithBSA&Azideat0.2mg/mL) |
EUR 230 |
Albumin (Transport Protein) |
|
MBS4380889-01mgWithBSAAzideat02mgmL |
MyBiosource |
0.1mg(WithBSA&Azideat0.2mg/mL) |
EUR 405 |
Every gynecologic cytology specimen examined by each a CT and a CP from December 2004 to March 2015 was extracted from the laboratory info system; glandular interpretations have been excluded. Excel and SAS have been used for CT-CP pair evaluation. CT-CP pairs with fewer than 32 specimens (the bottom quartile) have been excluded. For the remaining CT-CP pairs, 30 specimens or 10% of the specimens (whichever was greater) have been randomly chosen for comparability by a weighted κ statistic. κ values larger than 0.6 represented good settlement inside CT-CP pairs.